Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
GILEAD SCIENCES, INC. | SVP, Controller & CAO | Common Stock | 32K | $2.75M | $85.78 | Feb 6, 2023 | Direct |
GILEAD SCIENCES, INC. | SVP, Controller & CAO | Restricted Stock Unit | 11.1K | $874K | $79.02 | Feb 6, 2023 | Direct |
IPI Legacy Liquidation Co | Director | Stock Option (right to buy) | 0 | Apr 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IMPLQ | IPI Legacy Liquidation Co | Apr 5, 2024 | 4 | $0 | 4 | Apr 9, 2024 | Director |
IMPL | IMPEL PHARMACEUTICALS INC | Jun 16, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
GILD | GILEAD SCIENCES, INC. | Feb 6, 2023 | 3 | -$48.8K | 4 | Feb 7, 2023 | SVP, Controller & CAO |
GILD | GILEAD SCIENCES, INC. | Jan 24, 2023 | 3 | -$105K | 4 | Jan 26, 2023 | SVP, Controller & CAO |
GILD | GILEAD SCIENCES, INC. | Dec 10, 2022 | 3 | -$13.1K | 4 | Dec 13, 2022 | SVP, Controller & CAO |
GILD | GILEAD SCIENCES, INC. | Nov 9, 2022 | 3 | -$126K | 4 | Nov 10, 2022 | SVP, Controller & CAO |
GILD | GILEAD SCIENCES, INC. | Nov 1, 2022 | 3 | -$106K | 4 | Nov 2, 2022 | SVP, Controller & CAO |
GILD | GILEAD SCIENCES, INC. | Sep 10, 2022 | 3 | -$9.66K | 4 | Sep 12, 2022 | SVP, Controller & CAO |
GILD | GILEAD SCIENCES, INC. | Aug 10, 2022 | 3 | -$67.3K | 4 | Aug 11, 2022 | SVP, Controller & CAO |
IMPL | IMPEL PHARMACEUTICALS INC | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
GILD | GILEAD SCIENCES, INC. | Jun 10, 2022 | 3 | -$8.99K | 4 | Jun 13, 2022 | SVP, Controller & CAO |
GILD | GILEAD SCIENCES, INC. | Mar 10, 2022 | 7 | -$54.2K | 4 | Mar 14, 2022 | SVP, Controller & CAO |
GILD | GILEAD SCIENCES INC | Feb 6, 2022 | 3 | -$33.2K | 4 | Feb 8, 2022 | SVP, Controller & CAO |
GILD | GILEAD SCIENCES INC | Jan 26, 2022 | 3 | -$26.5K | 4 | Jan 28, 2022 | SVP, Controller & CAO |
GILD | GILEAD SCIENCES INC | Aug 17, 2021 | 5 | -$60.2K | 4 | Aug 18, 2021 | SVP, Controller & CAO |
GILD | GILEAD SCIENCES INC | Aug 10, 2021 | 3 | -$62.8K | 4 | Aug 12, 2021 | SVP, Controller & CAO |
IMPL | IMPEL NEUROPHARMA INC | Jul 11, 2021 | 1 | $0 | 4 | Jul 13, 2021 | Director |